Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
Development of multiple complications in type 2 diabetes is associated with the increase of multiple markers of chronic inflammation.
Serum alpha-1-microglobulin as a predictor of multiple complications in type 2 diabetes mellitus patients.
Type 2 Diabetes Mellitus and Cognitive Impairment.
Damanik J, Yunir E.
Acta Med Indones. 2021 Apr;53(2):213-220.
The Role of Obesity in Type 2 Diabetes Mellitus-An Overview.
Chandrasekaran P, Weiskirchen R.
Int J Mol Sci. 2024 Feb 4;25(3):1882. doi: 10.3390/ijms25031882.
Type 2 diabetes mellitus in older adults: clinical considerations and management.
Bellary S, Kyrou I, Brown JE, Bailey CJ.
Nat Rev Endocrinol. 2021 Sep;17(9):534-548. doi: 10.1038/s41574-021-00512-2. Epub 2021 Jun 25.
A review of type 2 diabetes mellitus and cognitive impairment.
Kan W, Qu M, Wang Y, Zhang X, Xu L.
Front Endocrinol (Lausanne). 2025 Aug 4;16:1624472. doi: 10.3389/fendo.2025.1624472. eCollection 2025.
Meta-analysis of the effect of exercise intervention on cognitive function in elderly patients with type 2 diabetes mellitus.
Lu HH, Zhou Y, Chen C, Gu ZJ.
BMC Geriatr. 2024 Sep 19;24(1):770. doi: 10.1186/s12877-024-05352-z.
CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY.
Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD.
Endocr Pract. 2019 Dec;25(12):1346-1359. doi: 10.4158/GL-2019-0406. Epub 2019 Nov 4.
Imeglimin in type 2 diabetes.
Huston J, Schaffner H, Langley L, Skrable B, Ashchi A, Berner J, Gore A, Sheikh-Ali M, Sutton D, Goldfaden R.
Drugs Today (Barc). 2022 Sep;58(9):437-449. doi: 10.1358/dot.2022.58.9.3419555.
PIEZO1 mediates a mechanothrombotic pathway in diabetes.
Zhu W, Guo S, Homilius M, Nsubuga C, Wright SH, Quan D, Kc A, Eddy SS, Victorio RA, Beerens M, Flaumenhaft R, Deo RC, MacRae CA.
Sci Transl Med. 2022 Jan 5;14(626):eabk1707. doi: 10.1126/scitranslmed.abk1707. Epub 2022 Jan 5.
Hepatocellular carcinoma, multiple primary neoplasia, and their association with diabetes type 2.
Žabová L, Hříbek P, Klasová J, Příhodová K, Urbánek P.
Cas Lek Cesk. 2023 Summer;162(2-3):112-118.
Type 2 diabetes mediated heart failure: focus on early recognition and clinical strategies.
Chen X, Li W, Zheng J, Huang M, Wang J, Wu M.
Front Endocrinol (Lausanne). 2025 Sep 10;16:1630686. doi: 10.3389/fendo.2025.1630686. eCollection 2025.
